BRIEF-Genmab announces U.S. FDA approval of Darzalex (Daratumumab) for relapsed multiple myeloma
November 21, 2016 at 15:55 PM EST
* Genmab announces U.S. FDA approval of Darzalex (Daratumumab) for relapsed multiple myeloma and updates financial guidance
